AI-generated · cited to primary sources · not investment advice
The company has already achieved a revenue of ₹1,663 crore in the first nine months of FY26, surpassing the full-year target of ₹1,500 crore. (5 exceeded across 5 tracked commitments)
“Nine months average is coming at about Rs.570 crores. And this quarter, it will be more than that.”
The company exceeded its volume guidance for both NPK and SSP sales in FY26. (1 exceeded, 4 met across 5 tracked commitments)
“DAP/NPK: 1,65,000 MT Sulphuric Acid: 99,000 MT ... Expected to commence commercial production as March 2026”
See the full cited Management analysis of Krishana Phosch.
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.